Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to assess the safety, tolerability and pharmacokinetics of
aripiprazole tablets following oral administration to children and adolescents.
Phase:
Phase 2
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.